Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial.

Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial. J Crohns Colitis. 2021 Jul 05; 15(7):1130-1141.

View in: PubMed

subject areas

Administration, Oral
Colitis, Ulcerative
Double-Blind Method
Female
Humans
Maintenance Chemotherapy
Male
Middle Aged
Piperidines
Protein Kinase Inhibitors
Pyrimidines
Remission Induction

authors with profiles

David T. Rubin